✦ LIBER ✦

P1148 BASELINE FACTORS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR) IN PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN

✍ Scribed by Christensen, S.; Boeker, K.H.W.; Eisenbach, C.; Schuchmann, M.; Lutz, T.; Heyne, R.; Moog, G.; Mauss, S.; Jung, M.-C.; Teuber, G.; Emke, F.; Naumann, U.; Frank Doss, M.; Lucadou, A.v.; Alshuth, U.; Hueppe, D.

Book ID: 122077109
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 61 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61308-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting sustained virological respons

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Prediction of sustained virological resp

Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin

✍ Foster, Graham R.; Fried, Michael W.; Hadziyannis, Stephanos J.; Messinger, Diet 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 392 KB

P.238 High sustained virological respons

P.238 High sustained virological response (SVR) rates with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in haemodialysed CHC patients awaiting renal transplant

✍ M. Rendina; A. Schena; N.M. Castellaneta; F. Losito; A.C. Amoruso; G. Stallone; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 144 KB

[613] VIROLOGICAL RESPONSE AT 4 AND 12 W

[613] VIROLOGICAL RESPONSE AT 4 AND 12 WEEKS PREDICT HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE IN GENOTYPE 1 PATIENTS TREATED WITH PEGINTERFERON a-2a (40 kD) PLUS RIBAVIRIN

✍ P. Marcellin; S.J. Hadziyannis; T. Berg; J.M. Sanchez-Tapias; J.-P. Bronowicki; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 259 KB

522 Combination therapy with peginterfer

522 Combination therapy with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C and genotype 1 infection: Individual estimated probability of sustained virological response (SVR)

✍ O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivoge 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

1192 HIGH SUSTAINED VIROLOGICAL RESPONSE

1192 HIGH SUSTAINED VIROLOGICAL RESPONSE RATES WITH RESPONSE-GUIDED DANOPREVIR PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE, HCV GENOTYPE 1 PATIENTS: ATLAS STUDY FINAL RESULTS

✍ Marcellin, P.; Cooper, C.; Balart, L.A.; Larrey, D.G.; Box, T.D.; Yoshida, E.; L 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 65 KB